ArticleInternational journal of cancer2022

Comments on "Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476)".

Carlo Cattrini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.